Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 3:38 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | ARMISTICE CAPITAL LLC | 418,000 8.67% | 418,000 (New Position) | View |
| 2022-02-14 06:05 am Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | Altium Capital Management LP | 0 0% | -4,500,000 (Position Closed) | View |
| 2022-02-10 08:17 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | VANGUARD GROUP INC | 3,326,017 4.36% | 1,597,413 (+92.41%) | View |
| 2022-01-19 10:48 am Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | Empery Asset Management LP | 335,745 0.44% | -3,664,255 (-91.61%) | View |
| 2022-01-03 5:57 pm Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | SABBY MANAGEMENT LLC | 603,812 11% | -4,396,188 (-87.92%) | View |
| 2021-02-24 10:46 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | Altium Capital Management LP | 4,500,000 5.9% | 4,500,000 (New Position) | View |
| 2021-02-19 2:45 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | SABBY MANAGEMENT LLC | 5,000,000 11% | 4,416,667 (+757.14%) | View |
| 2021-02-18 10:49 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | Empery Asset Management LP | 4,000,000 5.25% | 3,664,255 (+1091.38%) | View |
| 2021-02-16 09:59 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | CVI Investments Inc. | 420,000 1.3% | 236,464 (+128.84%) | View |
| 2021-02-10 10:57 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | VANGUARD GROUP INC | 1,728,604 5.96% | 1,728,604 (New Position) | View |
| 2021-02-09 3:50 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | Hudson Bay Capital Management LP | 295,880 0.92% | 2,232 (+0.76%) | View |
| 2021-01-20 11:10 am Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | Empery Asset Management LP | 335,745 1.05% | -1,664,255 (-83.21%) | View |
| 2021-01-07 1:38 pm Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | SABBY MANAGEMENT LLC | 583,333 11% | -1,417,087 (-70.84%) | View |
| 2020-12-28 4:57 pm Sale | 13G | HEPION PHARMACEUTICALS INC HEPA | HIRSCHMAN ORIN | 1,173,230 4% | -826,770 (-41.34%) | View |
| 2020-12-09 06:49 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | HIRSCHMAN ORIN | 2,000,000 6.9% | 2,000,000 (New Position) | View |
| 2020-12-02 11:12 am Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | Empery Asset Management LP | 2,000,000 6.91% | 2,000,000 (New Position) | View |
| 2020-12-01 8:48 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | SABBY MANAGEMENT LLC | 2,000,420 11% | 2,000,420 (New Position) | View |
| 2020-02-14 4:19 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | Anson Funds Management LP | 181,394 4.9% | 181,394 (New Position) | View |
| 2020-02-10 3:16 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | CVI Investments Inc. | 183,536 5% | 183,536 (New Position) | View |
| 2020-02-05 3:25 pm Purchase | 13G | HEPION PHARMACEUTICALS INC HEPA | Hudson Bay Capital Management LP | 293,648 7.84% | 293,648 (New Position) | View |